Sens. Seek More Clarity On FDA's Mobile Medical App Stance
A bipartisan group of six senators on Wednesday urged the U.S. Food and Drug Administration to further clarify its stance toward the regulation of mobile medical applications after issuing recent guidance...To view the full article, register now.
Already a subscriber? Click here to view full article